Novartis Oral PNH New Drug Approved by FDA for Market, Effectively Increasing Hemoglobin Levels
阿豆学长长ov
发表于 2023-12-6 17:06:44
250
0
0
Novartis Pharmaceuticals announced on December 6th that the US Food and Drug Administration (FDA) has approved the launch of its Fabhalta (iptacopan), which is the first FDA approved oral monotherapy for the treatment of adult paroxysmal nocturnal hemoglobinuria (PNH). Phase III clinical trials have shown that this therapy helps to increase patients' hemoglobin levels without the need for blood transfusions. The therapy is expected to be launched in the United States in December.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Apple patent can detect user stress levels while watching content
- Putin: Cannot Let the West monopolize the AI field, Russia must improve its own level
- Apple Ge Yue: 151 out of the top 200 suppliers lead the world in intelligent manufacturing production in China
- Pfizer Announces Approval of Oral Migraine New Drug "Rimezepam orally disintegrating tablets" in China
- Pfizer Announces Approval of Oral Migraine New Drug "Rimezepam orally disintegrating tablets" in China
- New weight loss medicine surpasses Tesla! How does investor preference transfer affect the US stock market?
- Xiaopeng Motors will achieve high-level assisted driving in 2024, covering the road network of major cities nationwide
- Surprisingly! FDA Delays Approval of Eli Lilly's New Drug for Alzheimer's Disease
- The Novo Nordisk Foundation collaborates with Nvidia to develop an AI supercomputer for the discovery of new drugs and therapies
- ExxonMobil expects global oil demand to approach current levels by 2050
-
每经AI快讯,据亿航智能官微消息,公司EH216-S无人驾驶电动垂直起降航空器(eVTOL)获得巴西国家民航局颁发的试验飞行许可证书,并计划在巴西进行测试和试飞。关于EH216-S无人驾驶eVTOL在巴西的认证,中国民航局 ...
- 潇湘才子
- 昨天 08:41
- 支持
- 反对
- 回复
- 收藏
-
今年7月,美国三大海外“债主”所持美国国债齐刷刷缩水,其中日本美债持仓已降至去年10月以来最低。 根据美国财政部当地时间9月18日公布的国际资本流动报告(TIC),2024年7月,美国前三大海外“债主”日本 ...
- 520hacker
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯(记者俞立严)9月19日,蔚来全新品牌乐道的首款车型——乐道L60正式上市。新车定位家庭智能电动SUV,在采用BaaS电池租用服务后,L60的售价可低至14.99万元,电池租用月费最低为599元。乐道L6 ...
- anhao007
- 前天 11:03
- 支持
- 反对
- 回复
- 收藏
-
每经记者袁园 日前,国务院印发的《关于加强监管防范风险推动保险业高质量发展的若干意见》提出,以新能源汽车商业保险为重点,深化车险综合改革。 “车险综改”从2015年就已经开始逐步推进了,经过 ...
- moshulong
- 前天 21:50
- 支持
- 反对
- 回复
- 收藏